Use of high-sensitivity troponin assays predicts mortality in patients with normal conventional troponin assays on admission - Insights from a meta-analysis

Clinical Cardiology

Volumn 36, Issue 11, 2013, Pages 649-653

  Chatterjee, Saurav ^a,b   Kim, Jiwon ^a,b   Dahhan, Ali ^a,b   Choudhary, Gaurav ^a,b   Sharma, Satish ^a,b   Wu, Wen Chih ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TROPONIN;

ACUTE CORONARY SYNDROME; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR MORTALITY; HEART INFARCTION; HOSPITAL ADMISSION; HUMAN; PROGNOSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

AGED; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; HEART DISEASES; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; ODDS RATIO; PATIENT ADMISSION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TROPONIN; UP-REGULATION;

EID: 84888002179     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22196     Document Type: Article

References (35)

1. Thygesen K, Alpert JS, Jaffe AS, et al. Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction. Third universal definition of myocardial infarction. Eur Heart J. 2012; 33: 2551-2567.
2. Newby LK, Jesse RL, Babb JD, et al. ACCF 2012 Expert Consensus Document on Practical Clinical Considerations in the Interpretation of Troponin Elevations: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2012; 60: 2427-2463.
3. Feldman DN, Kim L, Rene AG, et al. Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 2011; 77: 1020-1030.
4. Kerr G, Ray G, Wu O, et al. Elevated troponin after stroke: a systematic review. Cerebrovasc Dis. 2009; 28: 220-226.
5. Haaf P, Drexler B, Reichlin T, et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation. 2012; 126: 31-40.
6. Reiter M, Twerenbold R, Reichlin T, et al. Early diagnosis of acute myocardial infarction in patients with preexisting coronary artery disease using more sensitive cardiac troponin assays. Eur Heart J. 2012; 33: 988-997.
7. Schreiber DH, Agbo C, Wu AH,. Short-term (90 min) diagnostic performance for acute non-ST-segment elevation myocardial infarction and 30-day prognostic evaluation of a novel third-generation high-sensitivity troponin I assay. Clin Biochem. 2012; 45: 1295-1301.
8. Higgins JP, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions. 2nd ed. Hoboken, NJ: The Cochrane Collaboration and John Wiley & Sons Ltd.; 2008.
9. Stroup DF, Berlin JA, Morton SC, et al. for Meta-analysis of Observational Studies in Epidemiology (MOOSE) group. Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA. 2000; 283: 2008-2012.
10. Whiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med. 2011; 155: 529-536.
11. Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997; 315: 629-634.
12. Chatterjee S, Biondi-Zoccai G, Abbate A, et al. Benefits of β blockers in patients with heart failure and reduced ejection fraction: network meta-analysis [published correction appears in BMJ. 2013;346:f596]. BMJ. 2013;346:f55.
13. Hochholzer W, Reichlin T, Twerenbold R, et al. Incremental value of high-sensitivity cardiac troponin T for risk prediction in patients with suspected acute myocardial infarction. Clin Chem. 2011; 57: 1318-1326.
14. Weber M, Bazzino O, Navarro Estrada JL, et al. Improved diagnostic and prognostic performance of a new high-sensitive troponin T assay in patients with acute coronary syndrome. Am Heart J. 2011; 162: 81-88.
15. Lindahl B, Venge P, James S,. The new high-sensitivity cardiac troponin T assay improves risk assessment in acute coronary syndromes. Am Heart J. 2010; 160: 224-229.
16. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009; 361: 868-877.
17. Reichlin T, Hochholzer W, Bassetti S, et al. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med. 2009; 361: 858-867.
18. Hammerer-Lercher A, Ploner T, Neururer S, et al. High-sensitivity cardiac troponin T compared with standard troponin T testing on emergency department admission: how much does it add in everyday clinical practice? J Am Heart Assoc. 2013; 2: e000204.
19. Antman EM, Tanasijevic MJ, Thompson B, et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med. 1996; 335: 1342-1349.
20. Lindahl B, Venge P, Wallentin L,; The FRISC Study Group. Relation between troponin T and the risk of subsequent cardiac events in unstable coronary artery disease. Circulation. 1996; 93: 1651-1657.
21. Lindahl B, Toss H, Siegbahn A, et al. The FRISC (Fragmin During Instability in Coronary Artery Disease) Study Group. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med. 2000; 343: 1139-1147.
22. Hassan AK, Bergheanu SC, Hasan-Ali H, et al. Usefulness of peak troponin-T to predict infarct size and long-term outcome in patients with first acute myocardial infarction after primary percutaneous coronary intervention. Am J Cardiol. 2009; 103: 779-784.
23. Antman EM,. Decision making with cardiac troponin tests. N Engl J Med. 2002; 346: 2079-2082.
24. Benamer H, Steg PG, Benessiano J, et al. Elevated cardiac troponin I predicts a high-risk angiographic anatomy of the culprit lesion in unstable angina. Am Heart J. 1999; 137: 815-820.
25. Lindahl B, Diderholm E, Lagerqvist B, et al. FRISC II (Fast Revascularization During Instability in CAD) Investigators. Mechanisms behind the prognostic value of troponin T in unstable coronary artery disease: a FRISC II substudy. J Am Coll Cardiol. 2001; 38: 979-986.
26. Mills NL, Lee KK, McAllister DA, et al. Implications of lowering threshold of plasma troponin concentration in diagnosis of myocardial infarction: cohort study. BMJ. 2012; 344: e1533.
27. Fox KA, Dabbous OH, Goldberg RJ, et al. Prediction of risk of death and myocardial infarction in the 6 months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ. 2006; 333: 1091.
28. Antman EM, Cohen M, Bernink PJ, et al. The TIMI risk score for unstable angina/non-ST-elevation MI: a method for prognostication and therapeutic decision making. JAMA. 2000; 284: 835-842.
29. Anderson JL, Adams CD, Antman EM, et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients with Unstable Angina/non-ST-elevation Myocardial Infarction) developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions and Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine. Circulation. 2007; 116: e148-e304.
30. Celik S, Giannitsis E, Wollert KC, et al. Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy. Clin Res Cardiol. 2011; 100: 1077-1085.
31. Morrow DA, Antman EM, Tanasijevic M, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol. 2000; 36: 1812-1817.
32. Heeschen C, Hamm CW, Goldmann B, et al. PRISM Study Investigators (Platelet Receptor Inhibition in Ischemic Syndrome Management). Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban. Lancet. 1999; 354: 1757-1762.
33. Kastrati A, Mehilli J, Neumann FJ, et al. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel retreatment: the ISAR-REACT 2 randomized trial. JAMA. 2006; 295: 1531-1538.
34. Newby LK, Ohman EM, Christenson RH, et al. Benefit of glycoprotein IIb/IIIa inhibition in patients with acute coronary syndromes and troponin T-positive status: the paragon-B troponin T substudy. Circulation. 2001; 103: 2891-2896.
35. Mills NL, Churchhouse AM, Lee KK, et al. Implementation of a sensitive troponin I assay and risk of recurrent myocardial infarction and death in patients with suspected acute coronary syndrome. JAMA. 2011; 305: 1210-1216.